跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
臺北醫學大學新藥開發研究中心
臺北醫學大學
電話
+886-2-27361661
網站
http://my2.tmu.edu.tw/site/tmubcc
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(27)
專案
(141)
研究成果
(826)
資料集
(70)
指紋
查看啟用 臺北醫學大學新藥開發研究中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
7%
Alternative Complement Pathway C3 C5 Convertase
8%
Anti-Inflammatory Drug
9%
Antiangiogenic
6%
Anticarcinogen
36%
Antiinfective Agent
6%
Antimitotic Agent
6%
Antioxidant
8%
Antiproliferative Activity
14%
Antitumor Activity
16%
Aromatic Hydrocarbon Receptor
6%
Binding Site
9%
Bioavailability
9%
Biological Activity
7%
Breast Cancer
20%
Calcium Ion
12%
Cancer Growth
13%
Carcinogenesis
5%
Caspase
8%
Caspase 3
14%
Cell Viability
6%
Chemotherapy
8%
Cisplatin
9%
Colorectal Cancer
28%
Combination Therapy
7%
Cyclooxygenase 2
7%
Cytotoxicity
22%
Disease
25%
Drug Delivery System
7%
Drug Development
7%
Drug Discovery
8%
Drug Resistance
7%
Enzyme-Linked Immunosorbent Assay
6%
Epidermal Growth Factor Receptor
12%
Flow Cytometry
5%
Gelatinase B
10%
Genotoxicity
9%
Glioblastoma
24%
Heat Shock Protein 90
6%
Histone Deacetylase
34%
Histone Deacetylase 1
8%
Histone Deacetylase 6
24%
Histone Deacetylase 8
7%
Histone Deacetylase Inhibitor
44%
Hydroxamic Acid
25%
Hypoxia
10%
Hypoxia Inducible Factor 1
11%
IC50
42%
Immunotherapy
6%
Indole
10%
Inflammation
9%
Injury
8%
Lead Compound
5%
Lipopolysaccharide
9%
Liver Cell Carcinoma
12%
Lung Cancer
16%
Macrogol
7%
Malignant Neoplasm
100%
Metastasis
5%
Microtubule Inhibitors
5%
Mitogen Activated Protein Kinase
9%
Mitogen Activated Protein Kinase 3
5%
Mouse
35%
Mouse Model
13%
Mucocutaneous Lymph Node Syndrome
5%
Nanocarrier
9%
Nanoparticle
11%
Neoplasm
51%
Non Small Cell Lung Cancer
19%
Nuclear Factor
8%
Nude Mouse
6%
Osthole
5%
Pancreas Cancer
12%
Pharmaceutical Chemistry
7%
Pharmacokinetics
11%
Phosphatidylinositol 3 Kinase
9%
Phosphotransferase
22%
Phosphotransferase Inhibitor
5%
Piperazinedione
5%
Prostate Cancer
15%
Protein Kinases
7%
Protein P53
12%
Reactive Oxygen Metabolite
16%
Receptor
6%
Restenosis
6%
Shikonin
5%
Small Interfering RNA
9%
STAT3 Protein
7%
Structure Activity Relationship
9%
Temozolomide
12%
Transforming Growth Factor
8%
Triple Negative Breast Cancer
11%
Tubulin
37%
Tumor Growth
21%
Tumor Necrosis Factor
7%
Vasculotropin
9%
Virtual Screening
12%
Visual Pigment
9%
Vorinostat
12%
Western Blot
18%
Biochemistry, Genetics and Molecular Biology
Acetylation
5%
Allele
5%
Angiogenesis
9%
Anticancer
22%
Antineoplastic Activity
12%
Aryl Hydrocarbon Receptor
6%
Autophagy
15%
Binding Site
6%
Cancer Cell
67%
Carcinogenesis
8%
Caspase
7%
Caspase 3
6%
Cell Cycle
8%
Cell Cycle Arrest
5%
Cell Death
16%
Cell Invasion
5%
Cell Migration
12%
Cell Proliferation
10%
Cohort Study
7%
Colon
7%
Cyclooxygenase
6%
Cytotoxicity
9%
down Regulation
8%
Drug Resistance
6%
Eicosanoid Receptor
7%
Endoplasmic Reticulum Stress
5%
Epidermal Growth Factor Receptor
8%
Gene Expression
9%
Genetic Divergence
8%
Genetic Polymorphism
6%
Genetics
8%
Genome-Wide Association Study
5%
Genotyping
8%
HDAC6
9%
Heat Shock Protein
5%
Histone Deacetylase
27%
Hypoxia Inducible Factor 1
9%
IC50
14%
Intravenous Immunoglobulin
5%
Kinase
12%
Messenger RNA
12%
Microtubule Assembly
6%
Mouse
11%
ORAI1
7%
P53
6%
Phosphotransferase
12%
Promoter Region
7%
Protein Expression
6%
Protein Kinases
5%
Signal Transduction
12%
Single-Nucleotide Polymorphism
16%
STIM1
5%
Survival Rate
6%
Tau
5%
Transforming Growth Factor
5%
Tubulin
8%
Tumor Progression
12%
Upregulation
6%
Western Blot
9%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
5%
Angiogenesis
6%
Anticarcinogen
6%
Antineoplastic Activity
6%
Autophagy
9%
Breast Cancer
8%
Calcium Ion
7%
Cancer Cell
33%
Cancer Growth
7%
Cancer Therapy
10%
Cell Death
6%
Cell Proliferation
7%
Colorectal Cancer
14%
Cyclooxygenase 2
5%
Cytotoxicity
7%
Disease
7%
Gene Expression
7%
Glioblastoma
8%
HDAC1
5%
Histone Deacetylase
14%
Histone Deacetylase Inhibitor
9%
IC50
7%
In Vitro
21%
Kawasaki Disease
9%
Lung Cancer
6%
Malignant Neoplasm
14%
Metastatic Carcinoma
9%
Microtubule
5%
Neoplasm
13%
Programmed Cell Death
19%
Reactive Oxygen Species
5%
Signal Transduction
8%
Tubulin
8%
Tumor Progression
8%
Upregulation
5%
Xenograft
6%